Skip to main content
Division of Cancer Prevention
Division of Cancer Prevention

Search form

Making cancer prevention possible

Main menu

  • Home
  • Major Programs
    • Cancer Prevention Fellowship Program (CPFP)
    • Early Detection Research Network (EDRN)
    • NCI Community Oncology Research Program (NCORP)
    • Alliance of Glycobiologists for Cancer Research
    • Barrett's Esophagus Translational Research Network (BETRNet)
    • Cancer Prevention Clinical Trials Network (CP-CTNet)
    • Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
    • Cancer Screening Research Network (CSRN)
    • Cancer Treatment Tolerability Consortium
    • Consortium for Imaging and Biomarkers (CIB)
    • HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network
    • Liquid Biopsy Consortium
    • Lung Cancer Screening Image Library
    • Multi-Cancer Detection (MCD) Research
    • NCI Cervical Cancer ‘Last Mile’ Initiative
    • Pancreatic Cancer Detection Consortium (PCDC)
    • Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
    • PREVENT Cancer Preclinical Drug Development Program (PREVENT)
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    • Small Cell Lung Cancer (SCLC) Consortium
    • Supportive Care and Symptom Management
    • Translational and Basic Science Research in Early Lesions (TBEL) Program
    • Translational Liver Cancer (TLC) Consortium
    • US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
  • Research Groups
    • Biometry
    • Breast and Gynecologic Cancer
    • Cancer Biomarkers
    • Chemopreventive Agent Development
    • Community Oncology and Prevention Trials
    • Early Detection
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Nutritional Science
    • Prostate and Urologic Cancer
  • Clinical Trials
    • Clinical Trials Search
    • Landmark Trials
    • Clinical Trials Management
    • Why I Joined a Clinical Trial
  • Funding & Grants
    • Funding Opportunities
    • Funded Grants
    • Grantsmanship Resources
  • Resources
    • Publication Search
    • Biorepositories
    • Cancer Data Access System
  • News & Events
    • News
      • CP-CTNet Newsletter - September 2022
    • Blog
    • Meetings and Events
    • Videos and Webinars
    • Infographics
  • About DCP
    • Scientific Scope
    • Commemoration of the 50th Anniversary of the National Cancer Act
    • Director
    • DCP Leadership
    • History and Timeline
    • Historical Resources
    • Staff Directory

You are here

  1. Home
  2.   »  Home
Cancer Immunoprevention Network (CIP-Net): Pathways, Targets, Immune Cells, Vaccines, Agents

NCI Funding Approved to Expand Research on Immunoprevention, Natural Products

Cancer Immunoprevention Network (CIP-Net): Pathways, Targets, Immune Cells, Vaccines, Agents

The National Cancer Institute’s (NCI’s) Board of Scientific Advisors (BSA) recently approved two new concept proposals aimed at expanding potential prevention interventions. One will strengthen research in the nascent field of immunoprevention, and the other will accelerate the development of novel natural products for intercepting cancer at the earliest stages of disease. 

Cancer Immunoprevention Network (CIP-Net): Pathways, Targets, Immune Cells, Vaccines, Agents
CT scans images to improve lung cancer screening.

Leveraging Artificial Intelligence to Improve Accuracy of Lung Cancer Screening

CT scans images to improve lung cancer screening.

By the time lung cancer is diagnosed, the disease has often already spread outside the lung. Therefore, researchers have sought to develop methods to screen for lung cancer in high-risk populations before symptoms appear. They are evaluating whether the integration of artificial intelligence – the use of computer programs or algorithms that use data to make decisions or predictions – could improve the accuracy and speed of diagnosis, aid clinical decision-making, and lead to better health outcomes.

CT scans images to improve lung cancer screening.

MISSION STATEMENT

The Division of Cancer Prevention furthers the mission of the National Cancer Institute by leading, supporting, and promoting rigorous, innovative research and training to prevent cancer and its consequences to improve the health of all people.

Read more about Our Research

 

Latest News

Read All News

ULACNet Update - January 2023

Welcome to ULACNet Update, where we share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention...
January 30 | DCP News

CPFP Associate Director Position Available

The Cancer Prevention Fellowship Program (CPFP) at the National Cancer Institute is the flagship multidisciplinary...
January 18 | DCP News

Agent Development Program Director Position Available

Chemopreventive Agent Development Research Group, Division of Cancer Prevention The National Cancer Institute (NCI), Division of Cancer Prevention (...
January 12 | DCP News

CP-CTNet Newsletter - December 2022

Staff Highlight, DMACC Updates (Data Management and Reporting Unit, CP-CTNET DMACC Public Website and Portal Gateway Update, Clinical Trials Auditing...
December 16|CP-CTNet DMACC Website

Meetings and Events

Review All Our Meetings and Events

TEAG Forum: NCI Drug Development Resources: PREVENT and NExT Programs

Date(s):
  • Monday, February 13, 2023 - 11:00am - 12:00pm EST

Location: Virtual via WebEx

Twitter Feeds

@NCIprevention

Tweets by NCIprevention

@NCISymptomMgmt

Tweets by NCISymptomMgmt

@NCICastle

Tweets by NCICastle

Follow us at:

@NCIPrevention

@NCISymptomMgmt

@NCICastle

The National Cancer Institute

Policies

DCP Home

Contact DCP

Policies

Disclaimer Policy

Accessibility

FOIA

HHS Vulnerability Disclosure

NCI's PDQ® Evidence-based Summaries

Cancer Prevention

Screening/Detection/Testing for Cancer

Supportive and Palliative Care

General Information

Cancer Prevention, Specific Cancers, Clinical Trials

Cancer Screening Topics For People Who Have No Symptoms

Managing The Side Effects of Cancer and Its Treatment

Coping With Cancer

US Preventive Services Task Force Recommendations About Cancer

NIH COVID-19 Resources

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®